Read Our Latest Issue Some advanced cancers can now be successfully treated by synthetic immune cells that are more powerful and longer-lasting than any found in the body Tumor immunologists have known for decades that the immune system can be an important ally in the fight against cancer. Most early attempts to recruit its potential proved disappointing, however. It turns out that investigators had not done enough to stimulate a key component of the immune system, a kind of master sergeant called the T cell. Without enhancing the ability of T cells both to identify and to attack cancer cells, researchers were, in effect, asking the immune system to go into battle with the biological equivalent of paper airplanes and pellet guns. This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.